baber/WOPTO huggingface dataset:
Patent CA-2508585-A1 (CA)
Title: Transdermal delivery system for treatment of cognitive disorders
Inventor: BRUINSMA GOSSE B
IPC: A61K9/70
Filed: 2005-05-30
Abstract: An improved transdermal delivery composition is provided containing a low molecular weight fatty acid, and a long chain fatty acid or a long chain fatty acid lower alkyl ester, wherein the long chain is between about 1 to about 21 carbons long and preferably, contains at least one cis-olefinic bond. Preferred long chain components are oleic acid and ethyl oleate while the preferred low molecular weight fatty acid is propionic acid. The product may be used for treating a cognitive disorder by administering phenserine through a subject's skin.
Patent CA-2509000-A1 (CA)
Inventor: HOFMANN GUENTHER
IPC: B29C48/13
Filed: 2003-11-26
Abstract: L'invention concerne un dispositif pour produire des tuyaux à nervures transversales, ledit dispositif comportant des demi-moules (16), qui circulent, respectivement au moyen d'une unité d'entraînement associée, le long de deux pistes de guidage (14) sans fin, en étant plaqués l'un contre l'autre. Les deux pistes de guidage (14) présentent un tronçon de formage (18) commun, un tronçon de retour (20) respectif et deux tronçons de changement de direction (22, 24) respectifs. Chaque tronçon de changement de direction (22, 24) présente un organe de changement de direction (26, 28) pourvu d'un bord de guidage arqué. Les pistes de guidage (14) présentent, le long du tronçon de formage (18) commun et le long des tronçons de retour (20), des éléments d'usure (30) allongés, constitués d'une matière plastique à faible usure, qui sont placés de manière interchangeable sur une unité de base (12) du dispositif (10) selon l'invention.
Patent CA-2513540-A1 (CA)
Inventor: ANDERS JOSEPH CLIFTON
IPC: H04L12/66
Filed: 2004-12-08
Abstract: The present subject matter is directed to an apparatus and methodology for recording, at a central data center, telephone conversations originating from remote locations. The present subject matter has particular utility to the penal (corrections) environment in that it discloses a methodology for recording and storing voice and related data at a central data center remote from either the origination or destination locations of a telephone call placed by an inmate in a prison or other facility. The disclosed technology permits storage of both voice and call related data at a remote facility in such a manner that the data is searchably accessible by authorized personnel at other remote locations by way of network or Internet connection to the central data center.
Patent CA-2514027-A1 (CA)
Title: Dynamic stabilization and control of an earthmoving machine
Inventor: MATROSOV IVAN
IPC: G08C17/02
Filed: 2005-07-29
Abstract: An earthmoving machine including a control system is disclosed. The machine comprises first and second satellite navigation antennas mounted in a longitudinal direction on the earthmoving machine. A third satellite navigation antenna is mounted on a pole attached to an operational element of the earthmoving machine. In one embodiment, the earthmoving machine is a bulldozer and the operational element is a blade of the bulldozer. The machine further comprises a gravity reference sensor and a plurality of gyroscopes mounted on the machine. A computer processor generates control signals based on sensor data received from the various components. The disclosed system and method allows for dynamically stable operation of the earthmoving machine at relatively fast speeds without the development of unwanted oscillations.
Patent CA-2518271-A1 (CA)
Title: Polyamide-polyether block copolymer
Inventor: PALVIN MARK S
IPC: C08G69/40
Filed: 2004-02-20
Abstract: Copolymers having linked internal polyether blocks and internal polyamide blocks have advantageous physical properties and solvent-gelling abilities.  The copolymer may be prepared from a reaction mixture that contains 1,4-cyclohexane dicarboxylic acid (CHDA) and poly(alkyleneoxy) diamine (PAODA).  Optionally, the reaction mixture contains no monofunctional compound reactive with either amine or carboxylic acid groups, however some of this monofunctional compound may be present. Dimer diamine and/or dimer acid may be present in the reaction mixture. A copolymer may also be prepared from a reaction mixture containing dimer acid and at least two diamine compound(s) including PAODA and short-chain aliphatic diamine having 2-6 carbons (SDA), wherein: a) the reaction mixture comprises x grams of PAODA and y grams of SDA, and x/(x+y) is 0.8-0.98; b) the reaction mixture weighs z grams, and x/z is at least 0.25; and c) the reaction mixture contains either no co-diacid, or comprises a small amount of co-diacid, wherein, if the reaction mixture comprises a small amount of co-diacid, then acid equivalents from co-diacid contribute less than 25% of the total acid equivalents present in the reaction mixture.
Patent CA-2519362-A1 (CA)
Title: Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcome
Inventor: WALLEY KEITH R
IPC: C12Q1/68
Filed: 2004-03-19
Abstract: The invention provides methods and kits for obtaining a prognosis for a patient having or at risk of developing an inflammatory condition. The method generally comprises determining a Plasminogen Activator Inhibitor-1 (PAI-1) genotype of a patient for one or more polymorphisms in the PAI-1 gene of the patient, comparing the determined genotype with known genotypes for the polymorphism that correspond with the ability of the patient to recover from the inflammatory condition and identifying patients based on their prognosis.  PAI-1 genotype screening may be useful in identifying patients who would benefit from increased monitoring by healthcare professionals, and/or possible therapeutic intervention, if the patient were to develop inflammation due to systematic inflammation response syndrome (SIRS), bacterial infection, bacteraemia, sepsis, septic shock, organ dysfunction, and trauma. The invention also provides for methods of identifying other polymorphisms that correspond with the ability of the patients to recover from the inflammatory condition.
Patent CA-2521219-A1 (CA)
Inventor: CERVENY JEAN-PAUL
IPC: B65D51/28
Filed: 2004-04-01
Abstract: The capsule (1) consists of a deformable membrane (2) with its base closed by a seal (3) to form an enclosed volume (V) for at least one substance (S) that is released when the seal is pierced by an integral rupturing component (4). After the seal has been pierced a mechanical pressure is applied to the membrane to expel the substance(s) from the capsule into a container that is fitted with a cap holding the capsule, enabling the substance(s) to be mixed with the container's contents.
Patent CA-2522966-A1 (CA)
Title: Distal protection device
Inventor: TASHJIAN PAUL
IPC: A61F2/01
Filed: 2004-04-22
Abstract: A distal protection device comprising a catheter (10), a flexible member (16, 18) movable from a first position to a second looped position extending laterally with respect to the catheter, such that a first loop opening extends substantially in a direction of blood flow as the first loop opening extends in a plane substantially parallel to a transverse axis of the catheter, and filtering material movable from a collapsed position to an expanded position in response to movement of the flexible member.
Patent CA-2525645-A1 (CA)
Title: Sterilized xenograft tissue
Inventor: STONE KEVIN R
IPC: A61K35/34
Filed: 2003-05-16
Abstract: The invention provides an article of manufacture comprising a substantially nonimmunogenic xenograft for implantation into humans. The invention also provides methods for preparing a xenograft by removing at least a portion of a soft tissue from a non-human animal to provide a xenograft; washing the xenograft in saline and alcohol; subjecting the xenograft to cellular disruption treatment; treating the xenograft with crosslinking agents, and digesting the xenograft with a proteoglycan-depleting factor and/or glycosidase. The invention further provides a method for sterilizing xenograft material, having the steps of obtaining substantially non-immunogenic xenograft material; treating the xenograft material with at least one crosslinking agent; and subjecting the crosslinked xenograft material to radiation treatment.
Patent CA-2526101-A1 (CA)
Title: Implantable polymeric device for sustained release of nalmefene
Inventor: COSTANTINI LAUREN
IPC: A61K9/26
Filed: 2004-05-27
Abstract: The present invention provides compositions, methods, and kits for administration of nalmefene for treatment of alcoholism, nicotine dependence, or another condition for which treatment with nalmefene is therapeutically beneficial. The invention provides a biocompatible nonerodible polymeric device which releases nalmefene continuously with generally linear release kinetics for extended periods of time. Nalmefene is released through pores that open to the surface of the polymeric matrix in which it is encapsulated.  The device may be administered subcutaneously to an individual in need of continuous treatment with nalmefene.
Patent CA-2528243-A1 (CA)
Inventor: ANDREAS BERNARD
IPC: A61F2/82
Filed: 2004-05-28
Abstract: A stent deployment system includes a catheter shaft, an expandable member mounted to the catheter shaft, and one or more stents or stent segments slidably positioned on the expandable member. The stent deployment system is adapted for deployment of stents or stent segments in very long lesions and in tapered and curved vessels. The stent deployment system facilitates slidable movement of a stent in a distal direction relative to the expandable member while inhibiting slidable movement in a proximal direction relative to the expandable member.
Patent CA-2528753-A1 (CA)
Inventor: LEKHTMAN DAVID
IPC: A43B7/32
Filed: 2005-12-02
Abstract: An outer sole includes an upper sole, a tread layer disposed below the upper sole, and a resilient mid-sole disposed between the upper sole and the tread layer. The mid-sole resists compression under load, and comprises at least one floating hinge extending transversely to the longitudinal axis of the sole. Each floating hinge includes an upper resilient convex leaf spring, a lower resilient convex leaf spring, and a U-spring joining the leaf springs together. Each leaf spring has a root and a head opposite the root. Each U-spring has a pair of integrally-formed legs, each upper leaf spring is integrally formed at the root thereof with the upper sole, and each lower leaf spring is integrally formed at the root thereof with the tread layer. The leaf springs of each floating hinge are integrally joined at their heads to one of the legs of the associated U-spring.
Patent CA-2528763-A1 (CA)
Title: Transparent molded article
Inventor: KITAHARA YOSHITAKA
IPC: C08G18/62
Filed: 2004-06-09
Abstract: A transparent shaped body is disclosed which is composed of a polythiourethane obtained by polymerizing monomer components containing the component (A) and component (B1) described below. Another transparent shaped body is also disclosed which is obtained by polymerizing monomer components containing the component (A), component (B1), component (B2) and component (C) described below. Component (A) is one or more polythiol compounds represented by the general formula (I): (I) (wherein m is 1, 2, 3, 4, 5 or 6). Component (B1) is one or more polyisocyanate compounds represented by the general formula (II):  (II) (wherein n1, n2 and n3 are independently 3, 4, 5, 6, 7 or 8). Component (B2) is one or more aliphatic diisocyanate compounds having a ring structure in the molecule. Component (C) is an aliphatic diol compound.
Patent CA-2530260-A1 (CA)
Title: Expansion-deflection coupling
Inventor: GIBBON KEN
IPC: H02G3/06
Filed: 2005-12-14
Abstract: The present invention provides an expansion-deflection coupling which allows for higher angular deflection, as well as greater axial expansion and compression with increased parallel offset movements. The coupling includes a pair of identical hubs adapted to accommodate conduits within, and a flexible hollow cylinder extending between the hubs, At least one mid-coupling is located within the cylinder, and at least two plastic funneled tubes, each of which extends securely within the cylinder between the mid-coupling and one of the hubs. One of the hubs is secured to a union coupling.
Patent CA-2532383-A1 (CA)
Title: Temperature guard system for a refrigerator
Inventor: WETEKAMP ROBERT L
IPC: F25D29/00
Filed: 2006-01-09
Abstract: A refrigerator includes a controller for regulating temperatures established in a fresh food compartment and a freezer compartment of the refrigerator. The controller is selectively operable in a temperature guard mode providing a  warm temperature alarm setting function and a lower interrupt setting function. When the warm temperature alarm is active, the controller monitors temperatures of each of the fresh food compartment and the freezer compartment. If either temperature exceeds a respective predetermined value for a predetermined time, an alarm is activated to indicate a warm temperature, condition. When the power interrupt alarm setting is selected, the controller senses an interruption and restoration of power. Once power is restored, if a temperature of either the fresh f'ood compartment or the freezer compartment has exceeded a respective predetermined value, an alarm is activated to indicate an over-temperature condition. In addition, a high temperature value and an actual temperature value are displayed.
Patent CA-2534150-A1 (CA)
Title: Method and device for filtering and damping vibrations
Inventor: VERDUN PHILIPPE
IPC: F16F13/04
Filed: 2004-03-31
Abstract: The invention relates to a device to filter and damp the vibrations between a first element subjected to an incident vibratory wave and a second element radiating a filtered vibratory wave. This device comprises an interface structure to transfer vibratory energy constituted by at least one elastic component and at least one dissipative component attached in parallel to the elastic component to ensure the filtration and damping of the incident vibratory wave, the dissipative component being constituted by two separate rigid frames ensuring, punctually or continuously, deflection functions, if required, by a lever arm effect, amplification of the vibratory energies generated by the elastic components towards a dissipative material positioned between them, the dissipative component providing damping for the elastic component.
Patent CA-2534768-A1 (CA)
Inventor: WILLIAMS BRIAN P
IPC: A47J43/046
Filed: 2006-01-25
Abstract: A blender jar defines a geometry to impart vertical movement to material being processed in the blender jar, and, alternatively or in combination, improves the horizontal movement to the blended material. By configuring one or more agitators on the floor of a jar, laminar flow or symmetric flow of material around the jar is disrupted. The material is forced in an upward direction in the jar and, therefore, into more frequent contact with the cutter blades rotating in the jar.
Patent CA-2535444-A1 (CA)
Title: Irradiated butene-1 polymer compositions
Inventor: DALPIAZ MICHAEL
IPC: C08L23/20
Filed: 2004-07-26
Abstract: An irradiated butene-1 polymer material characterized by high melt strength and softness, and composiiton of this high melt strength butene-1 polymer with non-irradiated butene-1 polymer materials having enhanced crystallization properties.
Patent CA-2535781-A1 (CA)
Title: Synchronization of multiple operational flight programs
Inventor: SUMNER ROGER THEODORE
IPC: G06F13/42
Filed: 2006-02-08
Abstract: A method for synchronizing frame clocks in a plurality of processors comprises the steps of sending data packets from each of the processors to each of the other processors wherein each of the processors receives the data packets and identifies two of the data packets having the largest phase difference. The largest phase difference is used to determine a target synchronization phase angle, and the period of a frame clock is adjusted so that the frame clock approaches the target synchronization phase angle.
Patent CA-2536492-A1 (CA)
Inventor: SAGAWA HIROAKI
IPC: A61P37/02
Filed: 2004-08-19
Abstract: It is intended to provide a process for producing cytotoxic lymphocytes characterized by involving the step wherein, by using a medium having a total concentration of serum and plasma in the medium of from 0% by volume and less than 5% by volume, at least one treatment selected from among the induction of cytotoxic lymphocytes, maintenance thereof and upscaled culture thereof is carried out in the presence of fibronectin, its fragment or a mixture of the same.
Patent CA-2538253-A1 (CA)
Title: Method and system for generating an image
Inventor: BACARELLA ANTONIO V
IPC: G06T7/20
Filed: 2004-11-02
Abstract: This invention relates generally to the field of electro-optical devices and more specifically to a method and system for generating an image.
Patent CA-2540600-A1 (CA)
Title: Phase-control in an external-cavity tuneable laser
Inventor: DE DONNO MARCO
IPC: H01S5/022
Filed: 2003-09-30
Abstract: A method of controlling an external-cavity tuneable laser which has a wavelength-elective tuneable mirror, in which wavelength selectivity is achieved by an electrical signal provided by an alternating voltage. The tuneable mirror has a liquid crystal material, a diffraction grating and a planar waveguide optically interacting with the grating. The diffraction grating and the waveguide form a resonant structure that reflects only a selected resonance wavelength from among all the other wavelengths impinging thereon. Depending on the amplitude of the voltage applied to the tunable mirror, the tuneable mirror reflects radiation only at a given wavelength. The lasing output wavelength of the laser is selected to correspond to the resonance wavelength of the tuneable mirror. Accurate selection of the emission wavelength (frequency) of the tuneable laser by the tuneable mirror can be derived from the analysis of the signal modulation induced by the AC voltage applied to the tuneable mirror.
Patent CA-2542789-A1 (CA)
Inventor: MARTENS MATTHIAS
IPC: G01N27/16
Filed: 2006-04-11
Abstract: Circuit comportant au moins un élément de mesure catalytique (1), dans lequel l'au moins un élément de mesure catalytique (1) est connecté à une tension d'alimentation (5) sans résistor de protection et sans dispositif de sécurité thermique disposé en amont. Le circuit rend possible le développement de dispositifs de mesure avec des éléments de mesure catalytique caractérisés par une consommation de courant particulièrement basse.
Patent CA-2543244-A1 (CA)
Title: A bath with interchangeable fittings
Inventor: CRICHTON DAVID
IPC: A47K3/00
Filed: 2004-10-22
Abstract: A bath includes in or associated with an upper wall or rim section of the bath at least one water connection, a neck water outlet fitting 2 interchangeably connectable to the water connection to when connected direct a flow of water generally centrally on to the neck and/or upper back of a bather reclining against the adjacent bath wall, and a shoulders water outlet fitting or fittings 15 interchangeably connectable to the water connection to when connected direct a flow of water on to the shoulders or front shoulder regions of a bather reclining against the adjacent bath wall.
Patent CA-2547256-A1 (CA)
Title: Adenovirus-transfected primary cells and methods of pathway mapping
Inventor: LI LI
IPC: C07K14/47
Filed: 2004-12-01
Abstract: A primary cell culture is transfected with a vector comprising a reporter gene operatively linked to a cis-element. Expression of a candidate regulatory protein is induced in the cell culture and its effects on the cis-element are assayed.
Patent CA-2547402-A1 (CA)
Inventor: BIESZCZAD PAUL A
IPC: B21C47/34
Filed: 2006-05-19
Abstract: A spiraling apparatus its provided that includes a rotatable deck having a deck plate that includes first and second sides. A plurality of first spools are rotatably attached to the first side of the deck plate. The first spools include a length of reinforcement wound thereon. A plurality of second spools are rotatably attached to the second side of the deck plate.  The second spools also include a length of reinforcement wound thereon. A tension regulating device is adapted to regulate tension in the reinforcement as the reinforcement is removed from the first and second spools during rotation of the deck.
Patent CA-2547488-A1 (CA)
Title: Fft architecture and method
Inventor: KRISHNAMOORTHI RAGHURAMAN
IPC: G06F15/00
Filed: 2004-12-03
Abstract: A Fast Fourier Transform (FFT) hardware implementation and method provides efficient FFT processing while minimizing the die area needed in an Integrated Circuit (IC). The FFT hardware can implement an N point FFT, where N =  rn is a function of a radix (r). The hardware implementation includes a sample memory having N/r rows, each storing r samples. A twiddle factor memory can store k twiddle factors per row, where 0 < k<r represents the number of complex twiddle multipliers available. An FFT module reads r rows from memory, performs an r-point complex FFT on the samples, followed by twiddle multiplication, and writes the results into an r x r register bank. The contents of the register bank are written in transposed order back to the sample memory. This operation is repeated N/r2 times for each stage and then repeated for n- stages to produce the N point FFT.
Patent CA-2548488-A1 (CA)
Title: Methods and compositions providing agronomically beneficial effects in legumes and non-legumes
Inventor: SMITH R STEWART
IPC: A01N63/20
Filed: 2004-12-23
Abstract: Methods and compositions for enhancing plant characteristics of leguminous and non-leguminous crops include combination treatments with at least one fungicide, insecticide, or combination thereof, and one or more plant inducers, such as nod factors. Optionally, an inoculant composition may be used with the invention to enhance nodulation and nitrogen fixation with legumes.
Patent CA-2554640-A1 (CA)
Title: Pharmaceutical composition for oral application and method for preparing thereof
Inventor: PIEPER WILFRIED
IPC: A61K9/14
Filed: 2005-02-09
Abstract: The present invention relates to a pharmaceutical composition for oral application comprising: i) an anthelmintic agent; ii) a first excipient having a porous structure with an inner surface of about 500 to 1500 m2/g and a surface area according to BET of up to about 5000 m2/g; as well as to a method of preparing such a composition.
Patent CA-2557791-A1 (CA)
Inventor: YOSHITAKE TAKASHI
IPC: A61K9/14
Filed: 2005-03-23
Abstract: Controlled-leaching preparations containing a physiologically active substance unstable in acids, in particular, pulsed-leaching preparations being slight in lag time fluctuation and enhanced in reliability of leaching performance.  There are disclosed controlled-leaching preparations comprising core (1) containing a physiologically active substance unstable in acids and a disintegrant and controlled-leaching coating (2) covering the core and containing a water-insoluble polymer, an enteric polymer and a fat-soluble wax.
Patent CA-2561587-A1 (CA)
Inventor: MAY JOHN CHARLES
IPC: H04W52/02
Filed: 2005-03-29
Abstract: A method for correcting operation of the sleep oscillator (116) of a wireless communications device (100). Sleep oscillator frequency is estimated (412) so as to compensate for estimated temperature induced errors. In estimating temperature induced errors, errors (504) in sleep oscillator frequency are treated as being temperature induced errors (522), but probable multipath errors are bounded (410, 520) to predetermined sleep clock error maxima (602) corresponding to sleep duration over which the error occurred.
Patent CA-2565993-A1 (CA)
Title: Salt of 4-or 5- aminosalicylic acid
Inventor: SPARATORE ANNA
IPC: A61K31/606
Filed: 2005-05-27
Abstract: The present invention provides L-arginine salts of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these L-arginine salts of 4-or 5-aminosalicylic acid as active ingredients, useful for the treatment of an inflammatory condition of the GI tract such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).